Cellverse is a deep med-tech-based startup developing next-generation, human-relevant platforms for preclinical research. The company works at the intersection of tissue engineering, 3D bioprinting, and AI to create ethical, data-driven alternatives to traditional animal testing. Cellverse's focus is to build reliable, scalable systems that mirror human biology more closely, supporting pharmaceutical R&D, therapeutic screening, and early-stage translational research.